Cyclophosphamide bioactivation pathway (CP bioactivation)

The cyclophosphamide bioactivation pathway is the multi-step metabolic process required to convert the prodrug cyclophosphamide into its active, DNA-alkylating metabolites [PharmGKB, 2021]. This process occurs primarily in the liver and is initiated by cytochrome P450 enzymes, most notably Cytochrome P450 2B6 (CYP2B6), Cytochrome P450 3A4 (CYP3A4), and Cytochrome P450 2C9 (CYP2C9), which catalyze the 4-hydroxylation of the parent compound [StatPearls, 2023]. The resulting 4-hydroxycyclophosphamide exists in a steady-state equilibrium with its tautomer, aldophosphamide. Aldophosphamide then undergoes spontaneous, non-enzymatic decomposition to yield phosphoramide mustard, the active cytotoxic agent, and acrolein, a reactive aldehyde responsible for urothelial toxicity [PubChem, 2024]. This pathway is essential for the drug's efficacy in treating various cancers and autoimmune disorders, as the parent compound itself lacks significant alkylating activity [NIH NCI, 2024]. Variations in the activity of the involved enzymes, due to genetic polymorphisms or drug-drug interactions, can lead to significant differences in therapeutic response and the risk of adverse effects like hemorrhagic cystitis [PubMed, 21559014]. Understanding this pathway is crucial for optimizing dosing and managing the toxicity profile of oxazaphosphorine alkylating agents.

Other names

Cyclophosphamide metabolismCP activation pathwayOxazaphosphorine bioactivation4-hydroxylation of cyclophosphamideCyclophosphamide-phosphoramide mustard conversion

Cyclophosphamide is a prodrug that is converted by hepatic cytochrome P450 enzymes (primarily CYP2B6) into 4-hydroxycyclophosphamide, which spontaneously tautomerizes to aldophosphamide. Aldophosphamide then decomposes into the active alkylating agent phosphoramide mustard and the toxic byproduct acrolein. Phosphoramide mustard forms interstrand and intrastrand DNA cross-links at the guanine N-7 position, which inhibits DNA replication and triggers apoptosis [StatPearls, 2023; PharmGKB, 2021].